Exhibit 10.1
 
FIRST AMENDMENT TO
ASSET PURCHASE AGREEMENT

This First Amendment (this “Amendment”) to the Asset Purchase Agreement dated
February 3, 2009 (the “Original Agreement”) between Warner Chilcott Company,
Inc., a Company organized under the laws of Puerto Rico (“WCCI”) and NexMed
Inc., a Nevada corporation (collectively, with NexMed (USA), Inc. as defined
below, referred to as “NexMed”) is entered into effective as of April 15, 2009.

RECITALS

A.
WCCI wishes to utilize the NexMed Facility (as defined below) for the purposes
of manufacturing Product and NexMed is willing to allow WCCI to utilize such
facility; and

B.
WCCI and NexMed now wish to amend the Original Agreement in accordance with the
terms of this Amendment; and

C.
NexMed (USA), Inc., a Delaware Corporation and the wholly owned subsidiary of
NexMed, Inc. is the owner of the NexMed Facility (as defined below) and hereby
joins in this Amendment to authorize its use subject to the limitations and as
provided below.

 
AGREEMENT

 
NOW, THEREFORE, WCCI and NexMed agree as follows:

 
1.           A new Section 5.7 is hereby inserted at the end of Article 5 of the
Original Agreement to read as follows:

“5.7 (a) Use of NexMed Facility and NexMed Resources.  Commencing May 15, 2009
and continuing through and ending on September 15, 2009 (the “Initial Term”),
during normal business hours, NexMed shall allow WCCI’s employees and
consultants reasonable access to and use of (i) the manufacturing areas and
manufacturing equipment in its facility located at 89 Twin Rivers Drive, East
Windsor, NJ 08520 (the “NexMed Facility”) for the sole purpose of manufacturing
Product as such term is defined in the Original Agreement (the “Manufacturing
Activities”) and (ii) three offices and seven cubicle work stations at the
NexMed Facility in connection with such Manufacturing Activities.  In addition,
NexMed shall provide the non-exclusive use of the following resources (the
“NexMed Resources”) in the NexMed Facility during the Initial Term:
 
(i) utilities, phone, computer and internet access reasonably necessary to
conduct the Manufacturing Activities (ii) reasonable technical assistance from
NexMed’s product manager with respect to the Manufacturing Activities; and (iii)
reasonable assistance from NexMed’s Information Technology, Shipping & Receiving
and Facilities Management departments in support of the Manufacturing
Activities.

                  (b) Fees and Term. In consideration for the use of the NexMed
Facility and NexMed Resources to be provided by NexMed under this Section 5.7,
WCCI shall pay NexMed an aggregate monthly fee of $50,000 payable in advance on
each of May 15, 2009, June 15, 2009, July 15, 2009 and August 15, 2009 (or if
such date is not a business day, the next business day) by wire transfer to an
account designated by NexMed (the “Fees”).  The Initial Term shall automatically
extend for successive 30 day periods (each, a “Subsequent Term”) unless either
party shall deliver written notice to the other at least 15 days prior to the
expiration of the Initial Term or a Subsequent Term, as applicable, that this
Agreement and the Term thereof is terminated.  The $50,000 monthly Fee shall
also be payable to NexMed upon the commencement of each Subsequent Term.
 

--------------------------------------------------------------------------------

 
(c) Conditions of Use of NexMed Facility and NexMed Resources. WCCI’s right to
use the NexMed Facility and NexMed Resources pursuant to this Amendment as
described above shall be subject to and conditioned upon WCCI’s compliance with
and WCCI hereby agrees to comply with the following covenants and conditions:

(i) WCCI shall comply with the terms and conditions of and shall and make timely
payment of the Fees to NexMed as set forth in Section 5.7 (a) and (b) above;
(ii) WCCI shall comply with all applicable governmental and quasi-governmental
rules, requirements, ordinances, codes, resolutions, orders and laws
(collectively, “Laws”) including, without limitation, all environmental Laws;
(iii) WCCI shall not make, add or remove any improvements, additions, fixtures,
alterations or changes to the NexMed Facility or NexMed Resources; (iv) WCCI
shall not assign, license, sublet or otherwise permit any other person or entity
to use or benefit from this Agreement, WCCI’s rights or obligations hereunder,
or the NexMed Facility or NexMed Resources; (v) upon the earlier of the
termination of this Agreement or completion of the Initial Term or Subsequent
Term, as the case may be, WCCI shall promptly vacate and cease using the NexMed
Facility and NexMed Resources,  shall restore the same to their respective
conditions existing as of the date of this Agreement, shall leave the same in
broom clean condition and shall remove all of its personal property therefrom;
(vi) WCCI shall be responsible for all damage to the NexMed Facility and NexMed
Resources caused by the acts or omissions of WCCI or its agents, employees,
contractors, consultants, servants, representatives or invitees; (vii) WCCI
shall maintain Worker’s Compensation Insurance and such other insurance in such
coverage amounts and to such extent as NexMed may reasonably require; (viii)
this Amendment shall be binding upon and inure to the benefit of the parties
hereto and their respective successors and permitted assigns; (ix) in addition
to all other remedies that NexMed shall have at law and in equity for WCCI’s
default or breach hereunder, WCCI hereby agrees to indemnify, defend and hold
NexMed (and its officers, directors, employees, agents, shareholders, lenders
and representatives) harmless from any and all claims, injuries, liabilities,
suits, proceedings, damages, fines, penalties, expenses, costs (including
reasonable attorneys fees) and other claims as a result of or arising from its
breach or default of or under any of the terms, conditions or covenants in this
Amendment or its use of the NexMed Facility or NexMed Resources; (x) this
Amendment and WCCI’s rights hereunder are subject and subordinate to the rights
of NexMed’s  existing and future lenders; and (xi) WCCI’s obligations pursuant
to this Amendment shall survive termination of this Amendment (including the
Original Agreement) and its use of the NexMed Facility and NexMed Resources.
 
   (c) NexMed Use of the NexMed Facility. It is understood and agreed that
NexMed shall be entitled to continue to use the NexMed Facility and NexMed
Resources during Initial Term and any Subsequent Term provided that such use
shall not interfere with WCCI's Manufacturing Activities hereunder.

--------------------------------------------------------------------------------

 
 
2.           Schedule 2.01(c) to the Original Agreement is deleted in its
entirety and replaced with the new Schedule 2.01(c) attached to this Amendment
as Attachment 1.

3.           All capitalized terms used in this Amendment and not otherwise
defined in this Amendment have the meanings assigned them in the Original
Agreement.

4.           Except as expressly stated in this Amendment, the Original
Agreement remains unchanged and in full force and effect.

IN WITNESS WHEREOF, WCCI and NexMed have executed this Amendment through their
duly authorized representatives, effective as of the date first set forth above.

WARNER CHILCOTT COMPANY, INC.

By:           /s/ Max A.
Torres                                                                           

Name:      Max A. Torres

Title:        General Manager, Business Operations

NEXMED INC.

By:           /s/ Vivian
Liu                                                                           

Name:      Vivian Liu

Title:        President and Chief Executive Officer

NEXMED (USA), INC.

By:           /s/ Hemanshu Pandya

Name:      Hemanshu Pandya

Title:        Chief Operating
Officer                                                                                     

--------------------------------------------------------------------------------

 
Attachment 1
Revised Schedule 2.01(C)

Schedule 2.01(c)
TRANSFERRED MANUFACTURING EQUIPMENT

                                                   
Selling
 
NexMed Asset
 
NexMed Asset
Description
 
Price
 
Number
 
Inventory Tag
AccuDose Dispenser tooling and molds
 
$40,000
 
30357 & 30158,59,60
 
Off site & 290,291,292
Ross PVM-4 mixer with Chiller
 
$37,000
 
N/A & 30086
 
N/A & 1073
Cozzoli, 5 nozzle filler
 
$26,000
 
30028 & 30221
 
621
Schmucker F/F/S 3 lane Poucher
$94,000
 
30012
 
226
FD/120 Filling Machine
 
$114,000
 
30252
 
1130
In process cold box (180,000 units)
$4,000
 
30278 & 20014
 
1077 & N/A
Finished Product Cold Box
 
$35,000
 
20008
 
N/A
                   
Total
   
$350,000
                                           

At Closing, Buyer shall pay fifty percent (50%) of the Manufacturing Purchase
Price to Seller.  Within thirty (30) days of the Initial Batch Manufacture
Completion Date, Buyer shall remove the Transferred Manufacturing Equipment from
Seller’s premises.  Buyer shall pay Seller the remaining fifty percent (50%) of
the Manufacturing Purchase Price on May 15, 2009.  All payments hereunder shall
be made by wire transfer of immediately available United States dollars into an
account designated by Seller.  All costs associated with the removal of the
Transferred Manufacturing Equipment shall be paid by Buyer.
 

--------------------------------------------------------------------------------